Gwen A. Melincoff - Insider Trading & Ownership

Entity
Individual
Location
C/O Tobira Therapeutics, Inc., 701 Gateway Boulevard, South San Francisco, CA
Summary
The estimated net worth of Gwen A. Melincoff is at least $1.69M dollars as of June 26, 2024. Gwen A. Melincoff is the Director of COLLEGIUM PHARMACEUTICAL, INC and owns shares of COLLEGIUM PHARMACEUTICAL, INC (COLL) stock worth about $1.69M.
All Insider Reports
All Insider Reports

Ownership of Gwen A. Melincoff

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
COLL COLLEGIUM PHARMACEUTICAL, INC Director $1.69M May 16, 2024
GANX Gain Therapeutics, Inc. Director Jun 24, 2024
PLX Protalix BioTherapeutics, Inc. Director Sep 29, 2023
SLNO SOLENO THERAPEUTICS INC Director May 25, 2023

Insider Transactions Reported by Gwen A. Melincoff:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.